Verrica Pharmaceuticals Inc.

VRCA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$46,329$69,547$34,273$15,752
Short-Term Investments$0$0$0$54,602
Receivables$77$4,416$487$0
Inventory$2,463$1,022$0$0
Other Curr. Assets$2,310$2,545$4,355$3,974
Total Curr. Assets$51,179$77,530$39,115$74,328
Property Plant & Equip (Net)$2,579$3,615$5,330$5,502
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$376$452$276$295
Total NC Assets$2,955$4,067$5,606$5,797
Other Assets$0$0$0$0
Total Assets$54,134$81,597$44,721$80,125
Liabilities
Payables$1,896$2,464$507$845
Short-Term Debt$13,605$700$297$41,944
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$13,511$13,860$2,655$3,266
Total Curr. Liab.$29,012$17,024$3,459$46,055
LT Debt$32,334$44,810$1,229$1,465
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$2,648$0$0$0
Total NC Liab.$34,982$44,810$1,229$1,465
Other Liabilities$0$0$0$0
Cap. Leases$2,018$2,636$1,526$1,716
Total Liabilities$63,994$61,834$4,688$47,520
Equity
Pref Stock$0$0$0$0
Common Stock$9$4$4$3
Retained Earnings-$307,027-$230,448-$163,453-$138,966
AOCI$0$0$0-$29
Other Equity$297,158$250,207$203,482$171,597
Total Equity-$9,860$19,763$40,033$32,605
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$54,134$81,597$44,721$80,125
Net Debt-$390-$24,037-$32,747$27,657